chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tingling and numbness in left arm and hand; tingling and numbness in left arm and hand; nausea; light headedness/dizziness; headaches; the patient was tired(experienced fatigue).; vomiting; she gave the patient another dose. This dose was the fourth dose of GARDASIL 9 that the patient had received; overdose; This spontaneous report was received from a consumer (the patient's mother) referring to her son, a 23-years-old male patient. His medical history and concurrent conditions were not reported. Drug reactions/allergies included insect stings. Concomitant therapies included influenza vaccine (FLU SHOTS).  On 05-JUN-2013, the patient was vaccinated with the first dose of human papilloma virus (hpv) rl1 6 11 16 18 31 33 45 52 58 virus-like protein (vlp) vaccine (yeast) (GARDASIL 9) injection in the right arm (exact dose, route of administration, lot # and expiration date were not provided) as prevention of Human papillomavirus (HPV). On 09-SEP-2013 and 25-JAN-2014, the patient received the second and third dose of human papilloma virus (hpv) rl1 6 11 16 18 31 33 45 52 58 virus-like protein (vlp) vaccine (yeast) (GARDASIL 9) injection (exact dose, route of administration, vaccination site, lot # and expiration date were not provided) as prevention of HPV. The three doses were administered by the patient's Pediatrician.  On 03-SEP-2021, the patient went to see a doctor who treated adult patients for the first time. The new doctor misread the patient's medical history and thought that the patient had never received human papilloma virus (hpv) rl1 6 11 16 18 31 33 45 52 58 virus-like protein (vlp) vaccine (yeast) (GARDASIL 9) before, so she gave the patient another dose (that was the fourth dose) (extra dose administered and accidental overdose), no exact dose, route of administration, vaccination site, lot # and expiration date were reported. On the same date, roughly four hours after the shot, due to the overdose, the patient began having adverse reactions that included nausea, light headedness and dizziness, vomiting, headaches, tingling and numbness in left arm and hand, and the patient was tired (experienced fatigue). No treatment for the events was given. At the time of the report, the patient was being checked into the emergency room, so he had not yet been admitted to the hospital or had any lab/diagnostics/studies performed. The Company is unable to retrieve the product because the vaccine was administered at a doctor's office and then thrown away. The outcome of the events was not recovered. No product quality complaint reported.  The causality assessment between human papilloma virus (hpv) rl1 6 11 16 18 31 33 45 52 58 virus-like protein (vlp) vaccine (yeast) (GARDASIL 9) and nausea, light headedness and dizziness, vomiting, headaches, tingling and numbness in left arm and hand, and fatigue was related.
This spontaneous report has been received from a physician concerning a patient of unknown age and gender. The patient's concurrent conditions and pertinent medical history were not reported. On 16-JUN-2015, the patient was vaccinated with an improperly stored dose of oral, ROTATEQ, (lot #, exp. date, strength and dose were not provided). No adverse effect reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse concerning a 5 year old male who, at 12 months old, was vaccinated with a dose of varicella virus vaccine. On 01DEC2003 it was reported that the patient "recently" developed 10-15 varicella breakthrough lesions. It was reported that he was exposed to the wild type varicella at school and that there had been an "outbreak" of wild virus of varicella in the school district. No testing was done. It was unknown if medical attention was sought.  No product quality complaint was involved. It was also reported that the patient's sister and female cousin were vaccinated with a dose of varicella virus vaccine live and also developed varicella breakthrough lesions. It was also reported that 12-14 children were vaccinated with a dose of varicella virus vaccine live and developed varicella. The nurse also reported that she did not keep these charts separate and was unable to answer the questions asked. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of flushing in a 27 year old male subject who was vaccinated with Engerix B for prophylaxis. The subject had no known drug allergies. The patient had no adverse events following receipt of prior vaccinations. Concurrent medications included Multivitamins. On 30 January 2007, the subject received the 1st dose of Engerix B (1 ml, unknown, left arm). The subject received two pediatric doses of Engerix B drawn up into one syringe for a total of 1.0 ml. On 30 January 2007, soon after vaccination with Engerix B, the subject became very flush, a rash appeared to the left and right side of his arms, left neck, and part of his face, and his blood pressure was 157/95 and 148/101 thirty minutes later. Per the reporter, the subjects blood pressure was high when he first came into the office. The healthcare professional considered the events were clinically significant (or requiring intervention). The subject was treated with Benadryl, and the events began to improve. The healthcare professional considered the events were probably related to vaccination with Engerix B.
perioral rash with blue tinge to lips, full body rash and low grade fever, fussiness
Pain, welling, redness, warmth, and rash at injection site which spread down the forearm approx 8 inches length and 4 inches in width
15mins p/admin of vax nasal congestion on exam by MD was wheezing; edema of eye lids; was responsive could speak; no cyanosis; no retracion; no urticaria; hx of asthma;
Fatigue, malaise, foggy-headed feeling; started in August 1999, got significantly worse in May 2000. November 1999 through March 2000 had severe knee and jaw pain. Had elevated liver enzymes and other GI symptoms since June 2000 and are ongoing. Vision changes noted over past several months. Had other symptoms, too numerous to list her; may or may not be related. Received follow-up Lymerix injections in June 1999 and May 31, 2000.
Information has been received from a pharmacist concerning a male who was vaccinated with Zostavax (Oka/Merck) (lot658082/0744U).  On the second day after vaccination, the patient developed a dark red, hot to touch and itchy, 3 inch injection site reaction.  On day 3 the redness decreased but the site became lumpy.  The patient was treated with TYLENOL and cool compresses.  This is one report of several reports received from the same source.  Additional information has been requested.
Started losing my voice; I can't clear my throat. It sounds scratchy. It has stayed like that. I spoke to my Nurse about it (in home nurse). She said it was "COVID voice."  I am now trying  to use some local honey (1 T in my coffee) and that doesn't help. I am going to see Ears, nose and throat doctor soon. I still work in real estate and need my voice to be clear. It's hard to push the air through.
injection site turned red, felt hot, and itched. I took Benadryl after the third day of these symptoms; I continued 2 Benadryl a day for the next 4 days and eventually the redness disappeared and 95% of the itching stopped - I still feel a tingle of itching every once in awhile.
Psoriasis came back/psoriasis started coming out on hips, bellybutton, buttocks, legs, hands, wrists/started coming out on elbows/one single plaque on scalp/plaques getting bigger; FEVER; USE ERROR- PLUM BUTTON WAS ACCIDENTALLY PRESSED; THROAT INFECTION; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGITIS (THROAT INFECTION), PSORIASIS (Psoriasis came back/psoriasis started coming out on hips, bellybutton, buttocks, legs, hands, wrists/started coming out on elbows/one single plaque on scalp/plaques getting bigger), PYREXIA (FEVER) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (USE ERROR- PLUM BUTTON WAS ACCIDENTALLY PRESSED) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis (Moderate to severe).   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 01-Mar-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PHARYNGITIS (THROAT INFECTION). On an unknown date, the patient experienced PSORIASIS (Psoriasis came back/psoriasis started coming out on hips, bellybutton, buttocks, legs, hands, wrists/started coming out on elbows/one single plaque on scalp/plaques getting bigger), PYREXIA (FEVER) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (USE ERROR- PLUM BUTTON WAS ACCIDENTALLY PRESSED). At the time of the report, PHARYNGITIS (THROAT INFECTION) was resolving, PSORIASIS (Psoriasis came back/psoriasis started coming out on hips, bellybutton, buttocks, legs, hands, wrists/started coming out on elbows/one single plaque on scalp/plaques getting bigger) had resolved with sequelae, PYREXIA (FEVER) outcome was unknown and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (USE ERROR- PLUM BUTTON WAS ACCIDENTALLY PRESSED) had not resolved.            It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant product use was reported.   Both the doses of vaccine administered one in once.  No treatment information was provided.  The reporter's causality with Humira (Adalimumab) for the events of use error- plum button was accidentally pressed and fever was not provided. The reporter's causality for the events of throat infection and psoriasis came back/psoriasis started coming out on hips, bellybutton, buttocks, legs, hands, wrists/started coming out on elbows/one single plaque on scalp/plaques getting bigger with Humira (Adalimumab) was no reasonable possibility.  The reporter's causality for the event of humira not working with Humira (Adalimumab) was a reasonable possibility.
within 3 minutes of injection, upper left jaw and tongue became numb (like reaction to bee sting).  staff and was taken to be examined and observed for half hour.BP was fine and numbness went to left lower jaw.  Did NOT become worse and all dispersed within  an hour,
The day after the vaccination my arm and shoulder into my back was so sore I could barely touch it.  It was sore for a week and then it got better.  After that it started to itch.  My face also was itching and across the top of my back.  The itch was excruciating and I tried topical ointment and Tylenol but nothing  stopped the itch.  After the week my arm around the injection  site swelled, was red and hot.  It still itched but was better.  I watched it to be sure it was not getting bigger or more heated.  It stayed that way for about four days and returned to normal.  It still itches but not as much.
Patient reported that approximately 2 days after receiving Typhoid/Typhim-Vi and Tdap/Adacel that he experienced headache, body aches, and a rash on his chest, back, and abdomen, stomach cramps, and an episode of diarrhea, all of which entirely resolved within four days of receiving the injections.
Booster dose of Moderna vaccine was given 4 months after 2nd dose and not at correct interval of 6 months after 2nd dose
She didn't feel well when driving from Pharmacy (where she received the vaccines) to coffee shop. When she got home she felt "really ill." She states she was unable to take her dog out and never drank her coffee. She went to the den to lie down and husband found her at 530pm "wiped out." She had a metallic taste in her mouth and was "freezing." She went to bed at 7pm and had chills. Saturday she continued to have chills and the metallic taste and no energy. Sunday was the same. She was unable to go to church. She went back to bed at 1:30 pm and got up at 3:30 pm. Her husband said her face was drawn and she was slurring her speech. He took her to the ER. CT Head and CTA Head and Neck were unremarkable. An MRI 9/2/18 showed a small acute ischemic infarct in the left insular cortex and tiny focal acute ischemic infarct in the left cerebellum. She was transferred to Medical Center for further care. Overnight on 9/3/18 she had episodes of atrial fibrillation and was started on ELIQUIS. Metoprolol was started as well for elevated heart rate. Echocardiogram and EKG were normal. She was discharged 9/4/18. She is doing well except some difficulty with words if she is tired. She also tires more easily. 10/16/2018 The patient is a 73 year old female who presents for a follow up visit. The patient's last visit was 1 month ago. The patient's chronic conditions included Dysthymia and hyperlipidemia. The patient feels well with minor complaints. The patient was here in September for a hospital follow up for CVA. The patient reports she is not experiencing any side effects on her new medications: ELIQUIS, Metoprolol, Fish Oil, and LIPITOR. She was experiencing a lot of fatigue with the Metoprolol 1/2 BID so Dr. changed it to 1 tab QHS and that has helped. The patient would like to know when she will be cleared to drive. She was referred to Dr. at her last visit, but has not been seen yet. The patient also states there are times she feels like she can't take a deep breath. The patient is declining the flu vaccine and further vaccinations because she the SHINGRIX made her "deathly ill." 11/19/2018 It has been 6 weeks since her stroke and she is doing very well. I have told her today that she can drive.
Started with itchy neck, but no rash.  Then got a rash on bilateral forearms and feet.  Raised, blotchy, itchy.  Some with tiny blisters inside of them.
a year later on an unspecified date was vaccinated with PNEUMOVAX 23 and "still got pneumonia"; a year later on an unspecified date was vaccinated with PNEUMOVAX 23 and "still got pneumonia"; the patient got really mad and was very upset that she was vaccinated and still got pneumonia; the patient got really mad and was very upset that she was vaccinated and still got pneumonia; This spontaneous report was received from a pharmacist via a field representative referring to a female patient of over 65 years old. Information about medical history, concurrent conditions, drug reactions/allergies and concomitant therapies was unknown.  On an unknown date, the patient was vaccinated with pneumococcal 13v conj vaccine (CRM197) (PREVNAR 13) for prophylaxis. On an unknown date (reported as a year after vaccination), the patient was vaccinated pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (vaccine dosage detail, route of administration, lot# and expiration date were not reported). And on an unknown date the patient still got pneumonia. The patient sought medical attention, and spent some time in an unspecified hospital on unspecified dates for pneumonia. The patient got really mad and was very upset that she was vaccinated and still got pneumonia. It was unknown if any intervention to prevent serious criteria or lab diagnostics/studies were performed for the event. The outcome of pneumonia was unknown. The causality between the event of pneumonia and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.  Upon internal review, pneumonia was determined to be medically significant.
Felt like she was hit by a train; Sweating; Freezing cold; Couldn't eat; Threw up and had the runs; Headache; Wiped out and drained/ out of it; Weak; Achy; Started to feel foggy in her head; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), FEELING ABNORMAL (Started to feel foggy in her head), ASTHENIA (Weak), PAIN (Achy) and PAIN (Felt like she was hit by a train) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 08-Mar-2021, the patient experienced FEELING ABNORMAL (Started to feel foggy in her head). On 09-Mar-2021, the patient experienced ASTHENIA (Weak), PAIN (Achy), HEADACHE (Headache) and FATIGUE (Wiped out and drained/ out of it). On 10-Mar-2021, the patient experienced PAIN (Felt like she was hit by a train), HYPERHIDROSIS (Sweating), FEELING COLD (Freezing cold), FEEDING DISORDER (Couldn't eat) and VOMITING (Threw up and had the runs). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) at a dose of UNK dosage form. On 07-Mar-2021, PAIN IN EXTREMITY (Arm was sore) had resolved. On 09-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, FEELING ABNORMAL (Started to feel foggy in her head), PAIN (Achy), PAIN (Felt like she was hit by a train), HYPERHIDROSIS (Sweating), FEELING COLD (Freezing cold), FEEDING DISORDER (Couldn't eat), VOMITING (Threw up and had the runs) and FATIGUE (Wiped out and drained/ out of it) was resolving and ASTHENIA (Weak) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
Pt c/o sweating and bitter taste in tongue. Vital was taken BP:144/78, HR:99, Oxygen:100. No EMS. Pt report taking Amour thyroid and hydrocodone daily. Pt was observed another 10mins. Pt felt better and cleared by nurse.
Normal reaction at first, tired, chills, fever, but for the first week I could hardly get out of bed, I was so tired. Would sleep 16 hours a day, at two weeks I was still very fatigued I went to doc to get flu n covid test in case, stated coughing too. A month later I got upper respiratory that I still have and have not been the same since getting it. Still fatigued.
Fever; Chills; dizziness; aches; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received second dose bnt162b2 (reported as PFIZER COVID 19 VACCINE, lot number: unknown, Lot number wasn't given when receiving shot), via an unspecified route of administration in right arm on 05Feb2021 07:45 AM at single dose for COVID-19 immunisation.  The patient did not have other medical history or known allergies.  There were no concomitant medications (no other medications in two weeks). The patient was not pregnant. The patient previously received first dose bnt162b2 (reported as PFIZER COVID 19 VACCINE), via an unspecified route of administration in right arm on 15Jan2021 07:45 AM at single dose for COVID-19 immunisation.  The patient experienced Fever, chills, dizziness, aches on 05Feb2021 07:15 PM. AE resulted in 'None of the above'. The patient did not receive treatment for the events. The patient did not have COVID prior vaccination. The patient had COVID tested post vaccination, type was Nasal Swab and result was negative. The outcome of the event was recovering.  Information on the Lot/Batch number has been requested.
I fell asleep for a day; fever; chills; dullness; body ache; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sales Representative. A 46-year-old female patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date after receiving the Pfizer vaccine the patient fell asleep for a day with fever, chills, dullness, and body aches. Reportedly the event manifested after use of the product. Outcome of the event was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
I did not have any symptoms, my wife and i were going to see our grandchildren. We always test before we go to visit to ensure that we do take anything to them, I used a home COVID-19 test, it did come back positive. I used my doctor's office portal to let him know that I tested positive for COVID-19. He sent a prescription for the Paxlovid to my pharmacy so that I could start taking it that day. Once I started the medication, I was testing negative within five days.
Swollen Arm - Near Injection Site; Arm Pain - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 015M20A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site). At the time of the report, VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site) outcome was unknown.            No treatment information was provided.
This spontaneous report was received from a pharmacist and refers to a 64-year-old female patient. The patient had no pertinent medical history, drug reactions or allergies nor concomitant therapies. On 15-MAY-2017, the patient was vaccinated with PNEUMOVAX23 (lot # L040178, expiration date: 18-AUG-2017), dose and route of administration were not reported), in the left arm as vaccination. On 16-MAY-2017, she developed warmth and tenderness at the injection site and a raised welt 8 inches, from where the vaccine was administered. Lab diagnostic studied were not preformed. An unspecified treatment was given for the adverse events. The outcome of the events was reported as not recovered. The relatedness between the events and PNEUMOVAX23 was not provided. Additional information has been requested.
rash on injection site; itchiness on right side of face; This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th February 2020, the patient received the 2nd dose of Shingrix. On 5th February 2020, immediately after receiving Shingrix, the patient experienced injection site rash and pruritus facial. On an unknown date, the outcome of the injection site rash and pruritus facial were unknown.   It was unknown if the reporter considered the injection site rash and pruritus facial to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 68 years or 69 years. The patient experienced rash on injection site and itchiness on right side of face right after receiving Shingrix. The reporter consented to follow up.
This shot was given at pharmacy. I had severe shoulder pain and arm numbness had MRI and CAT scans done after 3 months diagnosed with Parsonage Turner syndrome.